COMMUNIQUÉS West-GlobeNewswire

Eikon Therapeutics Appoints Johnny Bennett, Ph.D. to its Scientific Advisory Board
10/08/2026
Experienced Merck researcher will expand the Board’s drug discovery expertise MILLBRAE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical [...]
Surgery Partners, Inc. Announces Second Quarter 2026 Results Reaffirms Full Year 2026 Guidance
10/08/2026
Reaffirms Full Year 2026 Guidance BRENTWOOD, Tenn., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) (“Surgery Partners” or the “Company”), a leading short-stay surgical facility owner and operator [...]
CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates
10/08/2026
Prioritizing strategic partnership to advance neflamapimod into Phase 3 for the treatment of dementia with Lewy bodies (DLB) Neflamapimod awarded Innovation Passport Designation under the United Kingdom’s Innovative [...]
Glass House Brands to Host Second Quarter 2026 Earnings Call on August 13, 2026
10/08/2026
LONG BEACH, Calif. and TORONTO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (NYSE: GLAS) today announced that it will report financial results for the [...]
Alvotech to Report Financial Results for H1 2026
10/08/2026
REYKJAVIK, Iceland, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for [...]
Novo Nordisk and AWS enter strategic partnership to accelerate drug discovery through AI
10/08/2026
New AI co-innovation hub in London brings together AWS engineers, AI specialists, and applied scientists alongside Novo Nordisk research and development teams to increase productivity and help reduce the time to market [...]
Clene Announces Biomarker Analyses To Be Included in NDA Submission Supporting ALS Accelerated Approval
10/08/2026
Survival benefit is concentrated in participants with NfL biomarker response: CNM-Au8 ® -treated patients whose NfL declined or stabilized lived significantly longer than concurrently randomized controls Functional [...]
Park Dental Partners, Inc. Announces Agreement to Acquire Village Family Dental Services Organization - Enters North Carolina Market
10/08/2026
The transaction is expected to add 12 practice locations and 48 doctors in North Carolina MINNEAPOLIS, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Park Dental Partners, Inc. (NASDAQ: PARK). (the “Company”), a leading dental [...]
Cogent Biosciences Reports Recent Business Highlights and Second Quarter 2026 Financial Results
10/08/2026
On track for potential approval of bezuclastinib for GIST patients (PDUFA November 30) and NonAdvSM patients (PDUFA December 30) later this year; AdvSM New Drug Application submitted to FDA on June 30 Completed [...]
Spyre Therapeutics Announces Launch of SPY772 Program and Initiation of Phase 2 SKYLIGHT Trial in Hidradenitis Suppurativa
10/08/2026
SPY772 program aims to deliver best-in-indication efficacy and convenience in Hidradenitis Suppurativa through dual inhibition of TL1A and IL-17A/F in a long-acting coformulation Phase 2 SKYLIGHT trial designed to [...]
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader
10/08/2026
Establishes an integrated global platform spanning biosimilar R&D, manufacturing and commercialization Adds a major long-term growth pillar and extends Amneal’s growth profile into the 2030s BRIDGEWATER, N.J., Aug. [...]
Erasca Strengthens R&D Leadership with Appointment of Internationally Recognized Medical Oncologist Charles S. Fuchs, M.D., M.P.H., as President of R&D
10/08/2026
SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/ [...]
Alvotech to Report Financial Results for H1 2026
10/08/2026
REYKJAVIK, ICELAND (August 10, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, [...]
Elicio Therapeutics Announces Activation of the Investigator-Initiated Phase 1 Study of Neoadjuvant ELI-002 7P for Pancreatic Ductal Adenocarcinoma
10/08/2026
Phase 1 study conducted by Memorial Sloan Kettering (“MSK”) Cancer Center and funded by The Lustgarten Foundation Study to evaluate ELI-002 7P in combination with chemotherapy and checkpoint inhibition in the [...]
Telomir Announces Peer-Reviewed Publication Demonstrating Telomir-Zn Suppresses Tumor Growth in TNBC and Prostate Cancer Models
10/08/2026
Iron-Rescue Experiments Confirm Iron-Dependent Mechanism. Tumor Suppressor Gene Reactivation and Anti-Tumor and Anti-Metastatic Activity Across Multiple Models. MIAMI, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Telomir [...]
Rani Therapeutics to Participate in the Canaccord Genuity 46th Annual Growth Conference
10/08/2026
SAN JOSE, Calif., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on oral delivery of biologics, today announced that the company’s [...]
Replimune Announces Pricing of $150 Million Underwritten Offering
10/08/2026
BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL) (“Replimune”), a commercial-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced the [...]
Alpha Tau Registers for Dual Listing on the Tel Aviv Stock Exchange (TASE)
10/08/2026
JERUSALEM, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) (“Alpha Tau” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT ® , today announced its [...]
Life Biosciences Appoints Stephen Webster to Board of Directors
10/08/2026
Former Spark Therapeutics Chief Financial Officer brings deep biotech finance, commercialization, and governance expertise BOSTON, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Life Biosciences (“Life Bio”), a clinical-stage [...]

Pages